Cancer Incidence in Saudi Arabia: 2012 Data from the Saudi Cancer Registry

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2017 Sep 28

PMID 28952273

Citations 71

Authors

Shouki Bazarbashi

Haya Al Eid

Joan Minguet

Affiliations

Soon will be listed here.

Abstract

Background: In order to most appropriately allocate healthcare and research funding for cancer, it is important to have accurate population-based incidence data. The Saudi Cancer Registry (SCR) provides such information, covering the time period from 1994 to the present day. The current report concerns an overview of cancer incidence statistics for Saudi Arabia in 2012. Methods: The SCR collects data from healthcare facilities throughout the Kingdom of Saudi Arabia. All newly diagnosed cases of cancer are recorded, with information on site and histology. For the present report, age-standardised and age-specific incidence rates (ASR, AIR, respectively) were calculated, with attention to gender-specific and regional differences. Results: The total number of incident cases of cancer identified by the SCR in 2012 was 14,336, with 6,791 (47.5%) among males and 7,545 (52.6%) among females. Of this total, 11,034 cases (76.9%) occurred in patients of Saudi origin. For Saudi males, the overall ASR (inc. all cancer sites) was 78.1 per 100,000 people, while that for females was 86.7. Incidence varied by region, with the Eastern region and Riyadh displaying the highest ASRs for both males and females, and Hail and Jazan displaying the lowest. Incidence varied by gender, with colorectal cancer (13.3%), non-Hodgkin lymphoma (NHL; 8.4%), and leukaemia (8.2%) being the most common types in males, and breast (25.8%), thyroid (11.7%), and colorectal cancers (9.3%) being the most common in females. Conclusions: This analysis of cancer incidence in Saudi Arabia demonstrated significant differences according to gender, age, and region of the Kingdom. The data should help ensure the most appropriate allocation of resources, with the aim of minimising the healthcare burden associated with cancer.

Citing Articles

Methionine Synthase Reductase A66G Variant in Pediatric Acute Lymphoblastic Leukemia Patients.

Yasin E, Qutob H, Alserihi R J Hematol. 2024; 13(6):278-284.

PMID: 39697681 PMC: 11650555. DOI: 10.14740/jh1360.

Prevalence of malignancy in thyroid nodules with AUS cytopathology: A retrospective cross-sectional study.

Alshalaan A, Elzain W, Alfaifi J, Alshahrani J, Al Qahtani M, Al Qahtani H J Family Med Prim Care. 2024; 13(9):3822-3828.

PMID: 39464912 PMC: 11504824. DOI: 10.4103/jfmpc.jfmpc_249_24.

Real-World Survival Outcomes of First-Line Therapies in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Retrospective Analysis from Two Centres in Saudi Arabia.

Al-Mansour M, Aga S, Alharbi H, Alsulami M, Fallatah H, Albedaiwi T Cancers (Basel). 2024; 16(18).

PMID: 39335205 PMC: 11430578. DOI: 10.3390/cancers16183234.

Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update.

Alqarni S, Alamri M, Pushparaj P, Rather I, Iqbal Z, Asif M Bioinformation. 2024; 20(4):397-403.

PMID: 38854755 PMC: 11161890. DOI: 10.6026/973206300200397.

The epidemiological and clinicopathological features of breast cancer in Riyadh, Saudi Arabia.

Omer A, Bin Dayel S, Hummedi A, Almuhaimed N Saudi Med J. 2024; 45(3):288-294.

PMID: 38438204 PMC: 11115392. DOI: 10.15537/smj.2024.45.3.20230656.

References

Al-Ahmadi K, Al-Zahrani A . NO(2) and cancer incidence in Saudi Arabia. Int J Environ Res Public Health. 2013; 10(11):5844-62. PMC: 3863874. DOI: 10.3390/ijerph10115844. View

Hewitson P, Glasziou P, Watson E, Towler B, Irwig L . Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008; 103(6):1541-9. DOI: 10.1111/j.1572-0241.2008.01875.x. View

Mohagheghi M, Mosavi-Jarrahi A, Malekzadeh R, Parkin M . Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med. 2008; 12(1):15-23. View

Radi S . Breast Cancer awareness among Saudi females in Jeddah. Asian Pac J Cancer Prev. 2013; 14(7):4307-12. DOI: 10.7314/apjcp.2013.14.7.4307. View

Ravichandran K, Al-Hamdan N, Mohamed G . Knowledge, attitude, and behavior among Saudis toward cancer preventive practice. J Family Community Med. 2011; 18(3):135-42. PMC: 3237202. DOI: 10.4103/2230-8229.90013. View

Sankaranarayanan R . Screening for cancer in low- and middle-income countries. Ann Glob Health. 2014; 80(5):412-7. DOI: 10.1016/j.aogh.2014.09.014. View

Alghamdi I, Hussain I, Alghamdi M, Dohal A, El-Sheemy M . The incidence of leukemia in Saudi Arabia. Descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001-2008. Saudi Med J. 2014; 35(7):674-83. View

Abdo A, Sanai F . Viral hepatitis in Saudi Arabia. An unfinished story. Saudi Med J. 2015; 36(7):785-6. PMC: 4503895. DOI: 10.15537/smj.2015.7.12457. View

Al-Faleh F, Ayoola E, Al-Jeffry M, Arif M, Al-Rashed R, Ramia S . Integration of hepatitis B vaccine into the expanded program on immunization: The Saudi Arabian experience. Ann Saudi Med. 1993; 13(3):231-6. DOI: 10.5144/0256-4947.1993.231. View

10.

Ng S, Zaghloul S, Ali H, Harrison G, Popkin B . The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev. 2010; 12(1):1-13. DOI: 10.1111/j.1467-789X.2010.00750.x. View

11.

Hussain F, Iqbal S, Mehmood A, Bazarbashi S, Elhassan T, Chaudhri N . Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013; 6(2):58-64. DOI: 10.1016/j.hemonc.2013.05.004. View

12.

El Bcheraoui C, Basulaiman M, Wilson S, Daoud F, Tuffaha M, AlMazroa M . Breast cancer screening in Saudi Arabia: free but almost no takers. PLoS One. 2015; 10(3):e0119051. PMC: 4361643. DOI: 10.1371/journal.pone.0119051. View

13.

Midhet F, Sharaf F . Impact of health education on lifestyles in central Saudi Arabia. Saudi Med J. 2011; 32(1):71-6. View

14.

Alghamdi I, Hussain I, Alghamdi M, Dohal A, Almalki S, El-Sheemy M . The incidence rate of thyroid cancer among women in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008. J Immigr Minor Health. 2014; 17(3):638-43. DOI: 10.1007/s10903-014-0044-5. View

15.

Al-Zalabani A, Alharbi K, Fallatah N, Alqabshawi R, Al-Zalabani A, Alghamdi S . Breast Cancer Knowledge and Screening Practice and Barriers Among Women in Madinah, Saudi Arabia. J Cancer Educ. 2016; 33(1):201-207. DOI: 10.1007/s13187-016-1057-7. View

16.

Almadi M, Mosli M, Bohlega M, Al Essa M, AlDohan M, Alabdallatif T . Effect of public knowledge, attitudes, and behavior on willingness to undergo colorectal cancer screening using the health belief model. Saudi J Gastroenterol. 2015; 21(2):71-7. PMC: 4392578. DOI: 10.4103/1319-3767.153814. View

17.

Nelson H, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L . Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016; 164(4):244-55. DOI: 10.7326/M15-0969. View

18.

Al-Hazzaa H, Abahussain N, Al-Sobayel H, Qahwaji D, Musaiger A . Physical activity, sedentary behaviors and dietary habits among Saudi adolescents relative to age, gender and region. Int J Behav Nutr Phys Act. 2011; 8:140. PMC: 3339333. DOI: 10.1186/1479-5868-8-140. View

19.

Abdelhadi M . Breast cancer awareness campaign: will it make a difference?. J Family Community Med. 2012; 13(3):115-8. PMC: 3410058. View